HALBERT JON
Transaction: 05/15/2026
BUY
Change
+68,000
Price
$14.56
Filing
07/13/2026
Type
BUY
Caris Life Sciences, Inc.
CAI • Biotechnology
$31.63
▲ +0.52 (+1.67%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$8.95B
Growth
-6.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.04Manageable debt level · 0.66Healthy liquidity · 7.85Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:44 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$31.63
Change1.67%
Shares Out282.89M
Market Cap$8.95B
Enterprise Value$8.55B
52W Range14.19 - 42.50
Beta0.68
P/E85.11
P/S9.04
P/B15.12
P/FCF61.08
EV/Sales8.64
Price$31.63
Change1.67%
Shares Out282.89M
Market Cap$8.95B
Enterprise Value$8.55B
52W Range14.19 - 42.50
Beta0.68
P/E85.11
P/S9.04
P/B15.12
P/FCF61.08
EV/Sales8.64
EV/EBITDA53.67
EV/FCF58.35
Earnings Yield1.17%
FCF Yield1.64%
Dividend Yield0.00%
Gross Margin66.40%
Oper. Margin5.56%
Profit Margin-66.25%
Debt/Eq0.66
Current Ratio7.85
Quick Ratio7.85
Revenue 5Y-6.77%
Target$27.25
Target Upside-13.85%
Target Median$27.00
Target Range22.00 - 33.00
Volume11.27M
Avg Volume3.11M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
23/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive free cash flow · 0.04Manageable debt level · 0.66Healthy liquidity · 7.85Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-10-20
94/100
Bullish
Bullish
7
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$21.00
Mean
$25.25
Median
$24.00
High
$32.00
Insider Transactions
Recent executive and insider activity
Knowles Jonathan Kenneth Charles
Transaction: 05/29/2026
BUY
Change
+1,600
Price
$15.62
Filing
06/02/2026
Type
BUY
POSTE GEORGE
Transaction: 05/29/2026
BUY
Change
+1,600
Price
$15.62
Filing
06/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| HALBERT JON | BUY | +68,000 | $14.56 | 05/15/2026 | 07/13/2026 |
| Knowles Jonathan Kenneth Charles | BUY | +1,600 | $15.62 | 05/29/2026 | 06/02/2026 |
| POSTE GEORGE | BUY | +1,600 | $15.62 | 05/29/2026 | 06/02/2026 |
| HALBERT DAVID D | SELL | -40,712 | $15.25 | 05/15/2026 | 05/18/2026 |
| Brille Brian J | SELL | -13,987 | $15.25 | 05/15/2026 | 05/18/2026 |
| Spetzler David Baxley | SELL | -13,856 | $15.25 | 05/15/2026 | 05/18/2026 |
| Power Luke Thomas | SELL | -9,771 | $15.25 | 05/15/2026 | 05/18/2026 |
| Denton John Russel | SELL | -6,047 | $15.25 | 05/15/2026 | 05/18/2026 |
| Vacirca Jeff L | BUY | +31,050 | $16.15 | 05/11/2026 | 05/12/2026 |
| HALBERT DAVID D | BUY | +320,112 | Not reported | 03/06/2026 | 03/10/2026 |
| Brille Brian J | BUY | +83,162 | Not reported | 03/06/2026 | 03/10/2026 |
| Spetzler David Baxley | BUY | +83,162 | Not reported | 03/06/2026 | 03/10/2026 |
| Denton John Russel | BUY | +63,971 | Not reported | 03/06/2026 | 03/10/2026 |
| Power Luke Thomas | BUY | +63,971 | Not reported | 03/06/2026 | 03/10/2026 |
| Minor Lloyd | BUY | +2,492 | $20.06 | 02/26/2026 | 03/02/2026 |
| CASTLEMAN PETER M | BUY | +5,509 | $20.06 | 02/26/2026 | 02/27/2026 |
| PHILLIPS T DANNY | BUY | +3,739 | $20.06 | 02/26/2026 | 02/27/2026 |
| HALBERT JON | BUY | +2,492 | $20.06 | 02/26/2026 | 02/27/2026 |
| Fredrickson David Paul | BUY | +2,492 | $20.06 | 02/26/2026 | 02/27/2026 |
| Vacirca Jeff L | BUY | +2,492 | $20.06 | 02/26/2026 | 02/27/2026 |